社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
智通财经APP
提供港股、美股、A股等全球资本市场资讯
IP属地:广东
+关注
帖子 · 1.10万
帖子 · 1.10万
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
智通财经APP
智通财经APP
·
05-29 17:44
金山云2026年第一季度财报电话会议解析
金山云2026年第一季度财报电话会议解析
$金山云(KC)$
$金山云(03896)$
看
1.87万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
金山云2026年第一季度财报电话会议解析
智通财经APP
智通财经APP
·
05-29 16:51
港股IPO递表第787期:人用破伤风抗毒素提供商江西生物
港股IPO递表第787期:人用破伤风抗毒素提供商江西生物
看
1.97万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第787期:人用破伤风抗毒素提供商江西生物
智通财经APP
智通财经APP
·
05-29 16:14
理想汽车2026年第一季度财报电话会议解析
理想汽车2026年第一季度财报电话会议解析
$理想汽车-W(02015)$
$理想汽车(LI)$
看
2.12万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
理想汽车2026年第一季度财报电话会议解析
智通财经APP
智通财经APP
·
05-29 15:56
港股IPO递表第786期:中药饮片产品供应商新荷花
港股IPO递表第786期:中药饮片产品供应商新荷花
看
2.10万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第786期:中药饮片产品供应商新荷花
智通财经APP
智通财经APP
·
05-29 14:33
港股IPO递表第785期:内容资产运营商新榜
智通财经#新榜#港股IPO#递表#港股#新股解读#投资
看
2.03万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第785期:内容资产运营商新榜
智通财经APP
智通财经APP
·
05-29 14:12
港股IPO递表第784期:推土机制造商山推股份
智通财经#山推股份#港股IPO#递表#港股#新股解读#投资
看
2.13万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第784期:推土机制造商山推股份
智通财经APP
智通财经APP
·
05-29 14:04
港股IPO递表第783期:合成生物企业华恒生物
智通财经#华恒生物#港股IPO#递表#港股#新股解读#投资
看
2.17万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第783期:合成生物企业华恒生物
智通财经APP
智通财经APP
·
05-29 13:57
港股IPO递表第782期:医美服务品牌君绮医美
智通财经#君绮医美#港股IPO#递表#港股#新股解读#投资
看
2.17万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第782期:医美服务品牌君绮医美
智通财经APP
智通财经APP
·
05-29 13:50
与DoveTree战略合作纵深推进,晶泰控股(02228)平台价值获业界与市场双重认可
5月27日,晶泰控股(02228)
$晶泰控股(02228)$
宣布,公司与DoveTree的合作进展理想,并已收到最终协议项下约定的第二笔付款1900万美元。 智通财经APP了解到,近年来,得益于AI模型与流程持续迭代、数据持续沉淀,晶泰的“AI+机器人”平台型业务的规模效应愈发明显,在广泛的商业化合作带动下,晶泰已能通过订单、首付款、里程碑与分成的滚动兑现,持续验证自身平台能力。 而在去年与DoveTree达成的一项总订单规模约470亿港元(59.9亿美元)的管线合作,正是晶泰控股“AI+机器人”平台价值迈入规模化兑现的具象化表现。 在去年达成最终合作协议后,晶泰控股于10日内便收到了来自DoveTree的第一笔5100万美元首付款,不到一年时间,从IP转让完成到首个临床前候选分子进入IND-enabling阶段,基于里程碑触发第二笔付款,足以看出DoveTree合作的诚意以及对开发“AI+机器人”平台价值的积极态度。 如果投资者相信,后续节点仍能以类似节奏逐步兑现——这种“可预期的节奏”一旦建立,DoveTree系列管线就有可能从一次性里程碑,演变为可预测的经常性收入来源。晶泰2025年全年收入8.03亿元,同比增长201.2%,首次实现年度盈利。当合作款项开始规律性到账,盈利的可持续性就多了一层来自外部验证的支撑。 image.png “哈佛药神”的战略选择 晶泰控股与DoveTree达成合作协议之所以在全球业界引发广泛关注,不仅仅是因为此次合作金额规模巨大,还因为DoveTree背后的创始人——被称作“哈佛药神”的Gregory Verdine教授。 作为横跨科学、产业、投资三大领域的“传奇人物”,Gregory Verdine教授在业内可谓鼎鼎大名。 智通财经APP了解到,Greg
看
2.03万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
与DoveTree战略合作纵深推进,晶泰控股(02228)平台价值获业界与市场双重认可
智通财经APP
智通财经APP
·
05-29 13:48
港股IPO递表第781期:物流交易平台拉拉科技
智通财经#拉拉科技#港股IPO#递表#港股#新股解读#投资
看
2.07万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
港股IPO递表第781期:物流交易平台拉拉科技
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3513736945495657","uuid":"3513736945495657","gmtCreate":1550642924930,"gmtModify":1773820411832,"name":"智通财经APP","pinyin":"ztcjappzhitongcaijingapp","introduction":"提供港股、美股、A股等全球资本市场资讯","introductionEn":"智通财经APP","signature":"提供港股、美股、A股等全球资本市场资讯","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","hat":null,"hatId":null,"hatName":null,"vip":5,"status":2,"fanSize":2404,"headSize":11,"tweetSize":11029,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":[],"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":569522500137144,"gmtCreate":1780047882061,"gmtModify":1780048493978,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"金山云2026年第一季度财报电话会议解析","htmlText":"\n \n \n 金山云2026年第一季度财报电话会议解析 <a href=\"https://laohu8.com/S/KC\">$金山云(KC)$</a> <a href=\"https://laohu8.com/S/03896\">$金山云(03896)$</a>\n \n","listText":"金山云2026年第一季度财报电话会议解析 <a href=\"https://laohu8.com/S/KC\">$金山云(KC)$</a> <a href=\"https://laohu8.com/S/03896\">$金山云(03896)$</a>","text":"金山云2026年第一季度财报电话会议解析 $金山云(KC)$ $金山云(03896)$","images":[{"img":"https://static.tigerbbs.com/ccc37f828fb1b6799a53724459cba919"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569522500137144","isVote":1,"tweetType":2,"object":{"id":"299b40c558e5494996221e128e15d505","tweetId":"569522500137144","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/39ed42fa5001834805406681163/87QA6JreQ6MA.mp4","poster":"https://static.tigerbbs.com/ccc37f828fb1b6799a53724459cba919"},"viewCount":18714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569509586371488,"gmtCreate":1780044687556,"gmtModify":1780045221298,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第787期:人用破伤风抗毒素提供商江西生物","htmlText":"\n \n \n 港股IPO递表第787期:人用破伤风抗毒素提供商江西生物\n \n","listText":"港股IPO递表第787期:人用破伤风抗毒素提供商江西生物","text":"港股IPO递表第787期:人用破伤风抗毒素提供商江西生物","images":[{"img":"https://static.tigerbbs.com/b019042b02ab905db1da812426438b4d"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569509586371488","isVote":1,"tweetType":2,"object":{"id":"4d8d1b75f48c4518bb4332a69e49637c","tweetId":"569509586371488","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/bd92691e5001834805401865258/AilQhPH9p24A.mp4","poster":"https://static.tigerbbs.com/b019042b02ab905db1da812426438b4d"},"viewCount":19711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569500537914440,"gmtCreate":1780042499349,"gmtModify":1780043426777,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"理想汽车2026年第一季度财报电话会议解析","htmlText":"\n \n \n 理想汽车2026年第一季度财报电话会议解析 <a href=\"https://laohu8.com/S/02015\">$理想汽车-W(02015)$</a> <a href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a>\n \n","listText":"理想汽车2026年第一季度财报电话会议解析 <a href=\"https://laohu8.com/S/02015\">$理想汽车-W(02015)$</a> <a href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a>","text":"理想汽车2026年第一季度财报电话会议解析 $理想汽车-W(02015)$ $理想汽车(LI)$","images":[{"img":"https://static.tigerbbs.com/6b2aca16352dbf4edbff5fde54d4b1da"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569500537914440","isVote":1,"tweetType":2,"object":{"id":"fca9e384cc7c4ba6bec238f8614b80bd","tweetId":"569500537914440","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/60403e865001834805397617653/THolGkMx1R0A.mp4","poster":"https://static.tigerbbs.com/6b2aca16352dbf4edbff5fde54d4b1da"},"viewCount":21228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569496293516160,"gmtCreate":1780041407219,"gmtModify":1780043423063,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第786期:中药饮片产品供应商新荷花","htmlText":"\n \n \n 港股IPO递表第786期:中药饮片产品供应商新荷花\n \n","listText":"港股IPO递表第786期:中药饮片产品供应商新荷花","text":"港股IPO递表第786期:中药饮片产品供应商新荷花","images":[{"img":"https://static.tigerbbs.com/a79d4aa1a012c6e2356c62a46105eb1f"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569496293516160","isVote":1,"tweetType":2,"object":{"id":"639508c0e3d64de4bfea7928037dd526","tweetId":"569496293516160","videoUrl":"https://1254107296.vod2.myqcloud.com/27e1f7ecvodtransgzp1254107296/7bb9e6ea5001834805394729791/v.f30.mp4","poster":"https://static.tigerbbs.com/a79d4aa1a012c6e2356c62a46105eb1f"},"viewCount":20983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569475932258608,"gmtCreate":1780036412067,"gmtModify":1780037931555,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第785期:内容资产运营商新榜","htmlText":"\n \n \n 智通财经#新榜#港股IPO#递表#港股#新股解读#投资\n \n","listText":"智通财经#新榜#港股IPO#递表#港股#新股解读#投资","text":"智通财经#新榜#港股IPO#递表#港股#新股解读#投资","images":[{"img":"https://static.tigerbbs.com/0f0de0d2ae50b858950b660b0126add1"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569475932258608","isVote":1,"tweetType":2,"object":{"id":"744e8c7f28e948e38fb48b22585308fb","tweetId":"569475932258608","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/73ebab9d5001834805387606080/Var1YJ7GmRsA.mp4","poster":"https://static.tigerbbs.com/0f0de0d2ae50b858950b660b0126add1"},"viewCount":20298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569470455193728,"gmtCreate":1780035154566,"gmtModify":1780035963010,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第784期:推土机制造商山推股份","htmlText":"\n \n \n 智通财经#山推股份#港股IPO#递表#港股#新股解读#投资\n \n","listText":"智通财经#山推股份#港股IPO#递表#港股#新股解读#投资","text":"智通财经#山推股份#港股IPO#递表#港股#新股解读#投资","images":[{"img":"https://static.tigerbbs.com/a6c9c04b5bf49ee85927b8cb106f8ae5"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569470455193728","isVote":1,"tweetType":2,"object":{"id":"d6c01a394fb641afaa3e06f543c9b60e","tweetId":"569470455193728","videoUrl":"https://1254107296.vod2.myqcloud.com/27e1f7ecvodtransgzp1254107296/3b905ea55001834805383439295/v.f30.mp4","poster":"https://static.tigerbbs.com/a6c9c04b5bf49ee85927b8cb106f8ae5"},"viewCount":21279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569468462003696,"gmtCreate":1780034672847,"gmtModify":1780035957144,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第783期:合成生物企业华恒生物","htmlText":"\n \n \n 智通财经#华恒生物#港股IPO#递表#港股#新股解读#投资\n \n","listText":"智通财经#华恒生物#港股IPO#递表#港股#新股解读#投资","text":"智通财经#华恒生物#港股IPO#递表#港股#新股解读#投资","images":[{"img":"https://static.tigerbbs.com/ff3287f5c2f1c33af122b32faf397966"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569468462003696","isVote":1,"tweetType":2,"object":{"id":"9750c7f5a44a4fe4ba87eb411029d094","tweetId":"569468462003696","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/da9b492d5001834805385698861/mJsfhf62NzIA.mp4","poster":"https://static.tigerbbs.com/ff3287f5c2f1c33af122b32faf397966"},"viewCount":21693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569466782279208,"gmtCreate":1780034270265,"gmtModify":1780035953921,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第782期:医美服务品牌君绮医美","htmlText":"\n \n \n 智通财经#君绮医美#港股IPO#递表#港股#新股解读#投资\n \n","listText":"智通财经#君绮医美#港股IPO#递表#港股#新股解读#投资","text":"智通财经#君绮医美#港股IPO#递表#港股#新股解读#投资","images":[{"img":"https://static.tigerbbs.com/a95b25dbb079df6b78ca47f3d5a2fbf0"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569466782279208","isVote":1,"tweetType":2,"object":{"id":"b936b6b1ebb74d9083e2ae769f0b273b","tweetId":"569466782279208","videoUrl":"https://1254107296.vod2.myqcloud.com/27e1f7ecvodtransgzp1254107296/3be791fe5001834805383483307/v.f30.mp4","poster":"https://static.tigerbbs.com/a95b25dbb079df6b78ca47f3d5a2fbf0"},"viewCount":21685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":569465022329160,"gmtCreate":1780033838671,"gmtModify":1780035385695,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"与DoveTree战略合作纵深推进,晶泰控股(02228)平台价值获业界与市场双重认可","htmlText":"5月27日,晶泰控股(02228) <a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 宣布,公司与DoveTree的合作进展理想,并已收到最终协议项下约定的第二笔付款1900万美元。 智通财经APP了解到,近年来,得益于AI模型与流程持续迭代、数据持续沉淀,晶泰的“AI+机器人”平台型业务的规模效应愈发明显,在广泛的商业化合作带动下,晶泰已能通过订单、首付款、里程碑与分成的滚动兑现,持续验证自身平台能力。 而在去年与DoveTree达成的一项总订单规模约470亿港元(59.9亿美元)的管线合作,正是晶泰控股“AI+机器人”平台价值迈入规模化兑现的具象化表现。 在去年达成最终合作协议后,晶泰控股于10日内便收到了来自DoveTree的第一笔5100万美元首付款,不到一年时间,从IP转让完成到首个临床前候选分子进入IND-enabling阶段,基于里程碑触发第二笔付款,足以看出DoveTree合作的诚意以及对开发“AI+机器人”平台价值的积极态度。 如果投资者相信,后续节点仍能以类似节奏逐步兑现——这种“可预期的节奏”一旦建立,DoveTree系列管线就有可能从一次性里程碑,演变为可预测的经常性收入来源。晶泰2025年全年收入8.03亿元,同比增长201.2%,首次实现年度盈利。当合作款项开始规律性到账,盈利的可持续性就多了一层来自外部验证的支撑。 image.png “哈佛药神”的战略选择 晶泰控股与DoveTree达成合作协议之所以在全球业界引发广泛关注,不仅仅是因为此次合作金额规模巨大,还因为DoveTree背后的创始人——被称作“哈佛药神”的Gregory Verdine教授。 作为横跨科学、产业、投资三大领域的“传奇人物”,Gregory Verdine教授在业内可谓鼎鼎大名。 智通财经APP了解到,Greg","listText":"5月27日,晶泰控股(02228) <a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 宣布,公司与DoveTree的合作进展理想,并已收到最终协议项下约定的第二笔付款1900万美元。 智通财经APP了解到,近年来,得益于AI模型与流程持续迭代、数据持续沉淀,晶泰的“AI+机器人”平台型业务的规模效应愈发明显,在广泛的商业化合作带动下,晶泰已能通过订单、首付款、里程碑与分成的滚动兑现,持续验证自身平台能力。 而在去年与DoveTree达成的一项总订单规模约470亿港元(59.9亿美元)的管线合作,正是晶泰控股“AI+机器人”平台价值迈入规模化兑现的具象化表现。 在去年达成最终合作协议后,晶泰控股于10日内便收到了来自DoveTree的第一笔5100万美元首付款,不到一年时间,从IP转让完成到首个临床前候选分子进入IND-enabling阶段,基于里程碑触发第二笔付款,足以看出DoveTree合作的诚意以及对开发“AI+机器人”平台价值的积极态度。 如果投资者相信,后续节点仍能以类似节奏逐步兑现——这种“可预期的节奏”一旦建立,DoveTree系列管线就有可能从一次性里程碑,演变为可预测的经常性收入来源。晶泰2025年全年收入8.03亿元,同比增长201.2%,首次实现年度盈利。当合作款项开始规律性到账,盈利的可持续性就多了一层来自外部验证的支撑。 image.png “哈佛药神”的战略选择 晶泰控股与DoveTree达成合作协议之所以在全球业界引发广泛关注,不仅仅是因为此次合作金额规模巨大,还因为DoveTree背后的创始人——被称作“哈佛药神”的Gregory Verdine教授。 作为横跨科学、产业、投资三大领域的“传奇人物”,Gregory Verdine教授在业内可谓鼎鼎大名。 智通财经APP了解到,Greg","text":"5月27日,晶泰控股(02228) $晶泰控股(02228)$ 宣布,公司与DoveTree的合作进展理想,并已收到最终协议项下约定的第二笔付款1900万美元。 智通财经APP了解到,近年来,得益于AI模型与流程持续迭代、数据持续沉淀,晶泰的“AI+机器人”平台型业务的规模效应愈发明显,在广泛的商业化合作带动下,晶泰已能通过订单、首付款、里程碑与分成的滚动兑现,持续验证自身平台能力。 而在去年与DoveTree达成的一项总订单规模约470亿港元(59.9亿美元)的管线合作,正是晶泰控股“AI+机器人”平台价值迈入规模化兑现的具象化表现。 在去年达成最终合作协议后,晶泰控股于10日内便收到了来自DoveTree的第一笔5100万美元首付款,不到一年时间,从IP转让完成到首个临床前候选分子进入IND-enabling阶段,基于里程碑触发第二笔付款,足以看出DoveTree合作的诚意以及对开发“AI+机器人”平台价值的积极态度。 如果投资者相信,后续节点仍能以类似节奏逐步兑现——这种“可预期的节奏”一旦建立,DoveTree系列管线就有可能从一次性里程碑,演变为可预测的经常性收入来源。晶泰2025年全年收入8.03亿元,同比增长201.2%,首次实现年度盈利。当合作款项开始规律性到账,盈利的可持续性就多了一层来自外部验证的支撑。 image.png “哈佛药神”的战略选择 晶泰控股与DoveTree达成合作协议之所以在全球业界引发广泛关注,不仅仅是因为此次合作金额规模巨大,还因为DoveTree背后的创始人——被称作“哈佛药神”的Gregory Verdine教授。 作为横跨科学、产业、投资三大领域的“传奇人物”,Gregory Verdine教授在业内可谓鼎鼎大名。 智通财经APP了解到,Greg","images":[{"img":"https://static.tigerbbs.com/feadf9cbc1e1faedcdbdeec15f435acb","width":"1106","height":"1051"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569465022329160","isVote":1,"tweetType":1,"viewCount":20340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":569464570020776,"gmtCreate":1780033698448,"gmtModify":1780034077819,"author":{"id":"3513736945495657","authorId":"3513736945495657","name":"智通财经APP","avatar":"https://static.tigerbbs.com/16db7768af5d7e4361472f092e918510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513736945495657","idStr":"3513736945495657"},"themes":[],"title":"港股IPO递表第781期:物流交易平台拉拉科技","htmlText":"\n \n \n 智通财经#拉拉科技#港股IPO#递表#港股#新股解读#投资\n \n","listText":"智通财经#拉拉科技#港股IPO#递表#港股#新股解读#投资","text":"智通财经#拉拉科技#港股IPO#递表#港股#新股解读#投资","images":[{"img":"https://static.tigerbbs.com/bac159e4077fc017157dd6d5337b3407"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/569464570020776","isVote":1,"tweetType":2,"object":{"id":"f65e1b30ab2f42189a85e1b4410473d4","tweetId":"569464570020776","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/9d59d9265001834805381291797/0xQCBDINWfAA.mp4","poster":"https://static.tigerbbs.com/bac159e4077fc017157dd6d5337b3407"},"viewCount":20707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}